Teleflex Incorporated (NYSE:TFX) Shares Purchased by Allworth Financial LP

Allworth Financial LP boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 504.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 254 shares of the medical technology company’s stock after acquiring an additional 212 shares during the period. Allworth Financial LP’s holdings in Teleflex were worth $34,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB increased its stake in shares of Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after acquiring an additional 100 shares during the last quarter. Headlands Technologies LLC acquired a new position in shares of Teleflex during the 4th quarter valued at about $29,000. Whipplewood Advisors LLC grew its holdings in shares of Teleflex by 7,700.0% in the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company’s stock valued at $32,000 after purchasing an additional 231 shares during the period. True Wealth Design LLC increased its position in Teleflex by 62.3% during the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 104 shares during the last quarter. Finally, UMB Bank n.a. raised its stake in Teleflex by 3,763.6% during the first quarter. UMB Bank n.a. now owns 425 shares of the medical technology company’s stock worth $59,000 after purchasing an additional 414 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Down 2.1%

TFX opened at $111.18 on Friday. Teleflex Incorporated has a 52 week low of $110.83 and a 52 week high of $249.91. The company has a quick ratio of 1.32, a current ratio of 2.28 and a debt-to-equity ratio of 0.44. The business has a fifty day simple moving average of $120.71 and a 200-day simple moving average of $141.51. The firm has a market cap of $4.91 billion, a P/E ratio of 35.07, a P/E/G ratio of 1.78 and a beta of 1.08.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. Teleflex’s revenue was down 5.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.21 EPS. On average, equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were given a $0.34 dividend. The ex-dividend date was Tuesday, May 20th. This represents a $1.36 annualized dividend and a yield of 1.22%. Teleflex’s dividend payout ratio is presently 42.90%.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Morgan Stanley dropped their price target on shares of Teleflex from $191.00 to $173.00 and set an “overweight” rating for the company in a research note on Monday, May 5th. Mizuho decreased their price objective on Teleflex from $150.00 to $130.00 and set a “neutral” rating on the stock in a report on Wednesday. Royal Bank Of Canada set a $130.00 target price on Teleflex and gave the stock a “sector perform” rating in a research note on Tuesday. Truist Financial reduced their target price on Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a research report on Monday, May 5th. Finally, Wells Fargo & Company decreased their price target on Teleflex from $146.00 to $137.00 and set an “equal weight” rating on the stock in a research note on Friday, May 2nd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $159.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.